News and Charts on Four Small Cap Telehealth and Remote Health Monitoring Plays.
After Losing $33 Billion in Value, Teladoc Health Snags an Upgrade.
With chances building...
Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...
Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.
We shoot and we score. Up 1,133% since adding to Watch List @ $3.00.
Our second...
Avicanna (AVCNF) $0.60 Conference Call.
8:30EST This Morning, Friday 11/12/21
Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call.
TORONTO,...
And We Have Our First MEME Stock! $2.00 to $29.95.
Tiny U.S. Biotech Jumps 930% as It Picks Up Retail Attention (Bloomberg)
Guess we were bound to stumble across...
ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites
Gentleman, Start Your Engines?
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...
October 26, 2021 07:30 AM Eastern Daylight Time
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology...
Institutional Analyst, Weekly Newsletter.
- Telehealth Watch List- 2021 Psychedelic Investor Guide out Wednesday.- Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company- Ehave (EHVVF) Announces Inclusion...
Telehealth Watch List.
We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.